Three former executives at Archer-Daniels-Midland (ADM) intentionally misled investors by inflating the performance of the company’s Nutrition unit, the Securities and Exchange Commission (SEC) has alleged.
The executives made and/or approved improper adjustments designed to hide a shortfall in ADM’s Nutrition unit, according to the SEC. As a result, the company overstated the unit’s operating profit for fiscal years 2019, 2021, and 2022, the SEC alleged.
